Skip to main content
Clinical Trials/JPRN-UMIN000053234
JPRN-UMIN000053234
Not yet recruiting
未知

Short-term weight loss and body composition changes in patients with obesity by GLP-1 and GIP/GLP-1 receptor agonists in combination with low-calorie diet. - Short-term therapeutic effects of GLP-1 and GIP/GLP-1 receptor agonists on patients with obesity during severe energy restriction.

Kimitsu Chuo Hospital0 sites40 target enrollmentDecember 31, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kimitsu Chuo Hospital
Enrollment
40
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 31, 2023
End Date
March 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kimitsu Chuo Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Patients who were or plan to be pregnant. (2\) Patients who were unable to cooperate with treatment due to mental illness or language barrier. (3\) Patients with a history of GLP\-1 receptor agonist use other than oral and subcutaneous semaglutide and tirzepatide. (4\) Patients who failed to continue GLP\-1 or GIP/GLP\-1 receptor agonists during hospitalization. (5\) Patients who were unable to continue the LCD provided by our hospital. (6\) Other patients deemed inappropriate as research subjects by the principal investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials